Back to search
Gastrointestinal Stromal Tumor, Malignant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Gastrointestinal Stromal Tumor, Malignant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Gastrointestinal Stromal Tumor, Malignant trials you may qualify forObjective: To follow people with GISTs and collect tumor tissue so that it can be studied in the lab. Eligibility: People age 6 and older who have a GIST. D…
In this clinical trial, the safety, tolerability, and preliminary antitumor activity of ziftomenib in combination with imatinib will be evaluated in adults with…
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
This is a prospective, multicenter, observational real-world study to explore the therapy patterns and clinical outcomes of Avapritinib in patients with metasta…
This is a prospective, multicenter, observational real-world study to explore the Avapritinib therapy in GIST patients who definited Non-exon18 Mutations of PDG…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
This phase II trial is studying how well sorafenib works in treating patients with malignant gastrointestinal stromal tumor that progressed during or after prev…